BetaShares Global Healthcare Currency Hedged ETF is a sector & thematic ETF from BetaShares — 66 holdings, with $163.0m under management. 99% of its money is in health care. Its two largest holdings, ELI LILLY & CO and JOHNSON & JOHNSON, make up 16% of the fund. It charges 0.57% a year.
Compare DRUG with another fund →About DRUG
- TypeSector & thematic
- IssuerBetaShares
- Size$163.0m
- Cost0.57% a year
- Holdings66
- Top sectorHealth Care 99%
- Top 2 holdings16%
Last week+1.8%
$8.93+1.82% price
DRUG rose 1.8% over the last week. On $10,000, that's +$182. ARGX was the biggest drag at −$12; ABBV helped most at +$44.
1W high$8.93
1W low$8.74
Avg volume90k
Latest volume263k
Prices to 12 Oct closeNo distributions in this period
What moved it
Gain or loss per $10k invested
- ABBVAbbVie+$44
- LLYEli Lilly+$21
- UNHUnitedHealth+$19
- MRNAModerna+$18
- ISRGIntuitive+$12
- ARGXArgenx−$12
- ELVElevance+$10
- Other 47 holdings+$100
- Other 45 holdings+$102
- UnattributedHedging, fees, timing−$32
- Fund return+$182
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.
All 66 holdings
HideCodeWeightContribution, 1W
Loading every holding…
Country
per $10k
- Other 4 countries−$0
- Other 2 countries−$2